Nxstage Medical Inc (NXTM) 22.09 $NXTM Technical Roundup

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nxstage Medical Inc (NXTM) 22.09 $NXTM

Technical Roundup on Medical Appliances and Equipment Stocks -- ZELTIQ Aesthetics, Align Technology, Nxstage Medical, and Nevro
PR Newswire - Mon Aug 01, 7:15AM CDT
One of the U.S. Healthcare sector's biggest segments, the Medical Appliances and Equipment is expected to face challenges due to stiff competition and economic uncertainties. However, constant need and demand for medical instruments should continue to drive industry growth, and the segment is anticipated to grow at a CAGR rate of about 6% through 2017, according to Espicom's 2014 report. Stock-Callers.com looks closely at the following stocks today: ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Align Technology Inc. (NASDAQ: ALGN), Nxstage Medical Inc. (NASDAQ: NXTM), and Nevro Corp. (NYSE: NVRO). Sign up today and download for free the research reports for the stocks covered today at:
NXTM: 22.09 (-0.02), ZLTQ: 33.57 (-0.38), ALGN: 89.69 (+0.54), NVRO: 82.34 (-0.36)

Bet on These 5 Profitable Stocks to Boost Your Returns
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 8:17AM CDT
One of the best tools to measure the future performance of a company's stocks is profitability analysis.
NXTM: 22.09 (-0.02), ALGN: 89.69 (+0.54), AL: 28.58 (-0.23), REI: 7.59 (-0.35), TAHO: 15.70 (+0.14)

Illumina (ILMN) Rallies on Exact Sciences Buyout Rumor
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 7:53AM CDT
With this buyout, Illumina (ILMN) will gain control over Cologuard -- a FDA approved non-invasive screening test of Exact Sciences that uses stool DNA technology to detect colorectal cancer.
NXTM: 22.09 (-0.02), GWPH: 96.11 (+1.79), TGTX: 5.79 (-0.12), ILMN: 170.65 (+4.30)

Boston Scientific's Restructuring Plan & Innovation Offer Hope
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 7:30AM CDT
On Jul 13, 2016, we issued an updated research report on Boston Scientific Corporation (BSX).
BSX: 24.43 (+0.15), NXTM: 22.09 (-0.02), GWPH: 96.11 (+1.79), NUVA: 63.29 (+1.09)

FDA Okays Medtronic's NuVent for Expanded Use in Sinusitis
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 7:17PM CDT
Medtronic's (MDT) NuVent is a unique balloon sinus dilation system, which enables a better view of one's sinus anatomy and the optimal placement of balloons during surgery.
NXTM: 22.09 (-0.02), MDT: 88.06 (+0.43), GWPH: 96.11 (+1.79), TGTX: 5.79 (-0.12)

Illumina Stock Hit by Downbeat Guidance, Stiff Competition
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 9:27AM CDT
Illumina (ILMN) faces high expenses related to the development of new products, their launch in various markets and investments in partnerships
ICUI: 117.07 (+0.31), NXTM: 22.09 (-0.02), GWPH: 96.11 (+1.79), ILMN: 170.65 (+4.30)

Halyard Health Now a Strong Buy, Portfolio Key Catalyst
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 7:54AM CDT
On Jul 8, 2016, Zacks Investment Research upgraded Halyard Health Inc (HYH) to a Zacks Rank #1 (Strong Buy).
HYH: 34.07 (-0.52), DSCI: 4.74 (-0.03), ICUI: 117.07 (+0.31), NXTM: 22.09 (-0.02)

Why Investors Love These Medical Appliances & Equipment's Stocks? - Align Technology, ZELTIQ Aesthetics, Amedica, and Nxstage Medical
PR Newswire - Wed Jun 22, 6:45AM CDT
Growth is expected for the U.S. Medical Appliances and Equipment industry as demand for healthcare continues to rise. In today's pre-market research, Stock-Callers.com shifts its attention on these four equities for investors' close review: Align Technology Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Amedica Corp. (NASDAQ: AMDA), and Nxstage Medical Inc. (NASDAQ: NXTM). Learn more about these stocks and receive your complimentary trade alerts at:
NXTM: 22.09 (-0.02), ZLTQ: 33.57 (-0.38), ALGN: 89.69 (+0.54), AMDA: 0.84 (+0.01)

Uptrend Call Working As NxStage Medical Stock Rises 33.4% (NXTM)
Comtex SmarTrend(R) - Fri Jun 10, 1:01PM CDT
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on March 7th, 2016 at $15.61. In approximately 3 months, NxStage Medical has returned 33.38% as of today's recent price of $20.82.
NXTM: 22.09 (-0.02)

Nxstage Medical (NXTM) Catches Eye: Stock Jumps 5.6%
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 7:40AM CDT
Nxstage Medical, Inc. (NXTM) saw its shares almost 6% in the last trading session.
NXTM: 22.09 (-0.02), BAX: 48.50 (+0.48)

Uptrend Call Working As NxStage Medical Stock Rises 25.8% (NXTM)
Comtex SmarTrend(R) - Fri Jun 03, 1:20AM CDT
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on March 7th, 2016 at $15.61. In approximately 3 months, NxStage Medical has returned 25.82% as of today's recent price of $19.64.
NXTM: 22.09 (-0.02)

NxStage Medical Has Returned 19.2% Since SmarTrend Recommendation (NXTM)
Comtex SmarTrend(R) - Thu May 26, 1:52PM CDT
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on March 7th, 2016 at $15.61. In approximately 3 months, NxStage Medical has returned 19.15% as of today's recent price of $18.60.
NXTM: 22.09 (-0.02)

NxStage Announces Second Quarter 2016 Investor Conference Schedule
PR Newswire - Tue May 24, 7:00AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank, Chief Executive Officer, plans to participate in the following schedule of investor conferences. Where applicable, a webcast of the event will be made available at http://ir.nxstage.com/.
NXTM: 22.09 (-0.02)

NxStage Medical Cuts Its Losses as Critical Care Leads Sales Higher
Dan Caplinger, The Motley Fool - Motley Fool - Wed May 04, 10:44AM CDT
Image source: NxStage Medical. Profitability often eludes small companies seeking to expand their businesses, and for home dialysis specialist NxStage Medical , the challenge of spending money on research and development while also marketing its...
NXTM: 22.09 (-0.02)

NxStage Reports First Quarter Financial Results
PR Newswire - Wed May 04, 7:05AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today reported first quarter financial results above the top end of its guidance.
NXTM: 22.09 (-0.02)

NxStage to Present at the Deutsche Bank 41st Annual Health Care Conference
PR Newswire - Mon Apr 25, 7:00AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank, Chief Executive Officer, plans to present at the Deutsche Bank 41st Annual Health Care Conference on Thursday, May 5, 2016 at 8:40 a.m. ET in Boston, MA. A webcast of the event will be made available at http://ir.nxstage.com/.
NXTM: 22.09 (-0.02)

Zerto Launches the Inaugural ZertoCON: The Next Generation Business Continuity Conference
PR Newswire - Wed Apr 13, 7:30AM CDT
Zerto, setting the standard for protection, recovery and migration of data in cloud and virtualized data centers, today announced the launch of ZertoCON, the next generation business continuity conference, taking place May 23-25, 2016 in Boston, MA. Executives, thought leaders and IT professionals from a wide range of industries and organizations - including Zerto's management and product leaders - will focus on building confidence in IT to move businesses forward.
NXTM: 22.09 (-0.02)

NxStage® to Report First Quarter 2016 Financial Results
PR Newswire - Mon Apr 11, 7:00AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced plans to release its financial results for the first quarter ended March 31, 2016, on Wednesday, May 4, 2016, before the opening of the financial markets.
NXTM: 22.09 (-0.02)

National Donate Life Month: NxStage Teams Up with Organ Donation Nonprofit MatchingDonors.com
PR Newswire - Thu Apr 07, 7:00AM CDT
Thirteen people die every day in the United States waiting for a kidney transplant, most waiting seven to nine years, according to the U.S. Department of Health and Human Services. April is National Donate Life Month and NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, is joining forces with MatchingDonors.com, the nation's largest nonprofit living organ donation website that provides people with an active way to search for an altruistic live donor. The organizations are teaming up to raise awareness of treatment options and services that may help kidney patients receive a transplant.
NXTM: 22.09 (-0.02)

Why NxStage Medical, Inc. Guided Lower Today
Brian Orelli, The Motley Fool - Motley Fool - Wed Feb 10, 3:48PM CST
What: NxStage Medical is down 14% near the closing bell after releasing disappointing guidance during its fourth-quarter earnings release this morning. So what: Fourth-quarter revenue was pretty strong, up 12% year over year. NxStage Medical...
NXTM: 22.09 (-0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 139

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
Nasdaq Tumbles: AI Hardware Pulls Markets Down

Updated Category News Views 184

Wall Street's Slide Fueled by AI Nerves The markets got a real jolt on Monday, sending Nasdaq down 2.5% thanks to a sharp dip in AI hardware stocks. Tech tickers tied to artificial intelligence were at the core of a sell-off, knocking the S&P 500 down 1.92% alongside it. Investors are on edge, and it’s not just the weather—it's a real shake-up driven by policy moves...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 207

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 146

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading
Québecor Makes Its Move: Eye on TELUS Amid Telecom Shakeup

Updated Category News Views 168

The Offer That Shocked the Telecom Markets Just when you think you’ve figured out the lay of the land, someone throws a curveball. Québecor’s decision to take a run at TELUS is shaking up Canada’s telecom scene big time. This isn’t just another M&A whisper; it’s a roaring freight train of a proposal valued at a whopping $31 billion. And TELUS, not just sitting...

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 108

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window

Updated Category News Views 79

A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 132

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 156

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading

Top 5 Most Recently Viewed Articles

James Lukezic's Triumph: FINRA Case Dismissed, Reputation Restored

Updated Category News Views 278

James Lukezic's Journey to Exoneration NEW YORK – After undergoing extensive hearings, James Lukezic, the Managing Principal of Old Slip Capital Management, has successfully cleared his name of unfounded allegations in a substantial FINRA case. This decision represents a significant milestone for Lukezic, who faced serious accusations surrounding five trades that...

Continue Reading
DraftKings Inc. Reports Impressive Q2 Growth and Strong Future Prospects

Updated Category News Views 175

DraftKings Inc. Achieves Record Revenue in Q2 DraftKings Inc. announced remarkable financial results for the second quarter, showcasing a significant leap in its performance. This includes a record revenue of $1.51 billion, representing a 37% increase year-over-year. This impressive growth surpassed analyst expectations, as the consensus estimate was only $1.39 billion....

Continue Reading
Trellis Bioscience's $9M Shot at Revolutionizing PJI Treatment

Updated Category News Views 40

New Hope on the Horizon for Joint Implant Infections When you hear about prosthetic joint infections (PJIs), 'devastating' doesn’t quite cover it. We’re talking something that’s hard to tackle, ends up costlier than a Beverly Hills tax bill, and drains quality of life like nothing else. Now, Trellis Bioscience seems to think there's hope on the way. The company just...

Continue Reading
Dionisio Gutiérrez Honored with Prestigious Award by Spain's King

Updated Category News Views 196

Dionisio Gutiérrez's Recognition and Achievements Dionisio Gutiérrez, a prominent figure known for his contributions to civic and business advancements, has recently been honored with the XI Enrique V. Iglesias Award. This prestigious accolade, presented by King Felipe VI of Spain, acknowledges Gutiérrez's significant impact within the Ibero-American space,...

Continue Reading
Vivani Medical Advances in Clinical Trials for GLP-1 Implant

Updated Category News Views 238

Vivani Medical, Inc. (NASDAQ: VANI) recently received approval from the Bellberry Human Research Ethics Committee and an acknowledgment from Australia’s Therapeutic Goods Administration for its first-in-human clinical trial. This significant step centers around the company's innovative GLP-1 (exenatide) implant targeting overweight and obese individuals, marking a...

Continue Reading